Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on November 27, 2006

Circulation. 2006
Published online before print November 27, 2006, doi: 10.1161/CIRCULATIONAHA.106.657270
A more recent version of this article appeared on December 12, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
114/24/2627    most recent
CIRCULATIONAHA.106.657270v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wall, S. T.
Right arrow Articles by Guccione, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wall, S. T.
Right arrow Articles by Guccione, J. M.
Related Collections
Right arrow CV surgery: transplantation, ventricular assistance, cardiomyopathy
Right arrow Quantitative modeling

Submitted on August 8, 2006
Revised on September 27, 2006
Accepted on October 5, 2006

Theoretical Impact of the Injection of Material Into the Myocardium. A Finite Element Model Simulation

Samuel T. Wall BS;, Joseph C. Walker PhD, Kevin E. Healy PhD, Mark B. Ratcliffe MD, and Julius M. Guccione PhD*

From the University of California at Berkeley/San Francisco, Joint Graduate Group in Bioengineering (S.T.W., J.C.W., K.E.H., M.B.R., J.M.G.); Departments of Material Science and Engineering (K.E.H.) and Bioengineering (K.E.H.), University of California at Berkeley; Department of Surgery, University of California at San Francisco (M.B.R., J.M.G.); and Veterans Affairs Medical Center, San Francisco, Calif (M.B.R., J.M.G.).

* To whom correspondence should be addressed. E-mail: Julius.Guccione{at}med.va.gov.

Background--To treat cardiac injuries created by myocardial infarcts, current approaches seek to add cells and/or synthetic extracellular matrices to the damaged ventricle to restore function. Because definitive myocardial regeneration remains undemonstrated, we propose that cardiac changes observed from implanted materials may result from altered mechanisms of the ventricle.

Methods and Results--We exploited a validated finite element model of an ovine left ventricle with an anteroapical infarct to examine the short-term effect of injecting material to the left ventricular wall. The model’s mesh and regional material properties were modified to simulate expected changes. Three sets of simulations were run: (1) single injection to the anterior border zone; (2) therapeutic multiple border zone injections; and (3) injection of material to the infarct region. Results indicate that additions to the border zone decrease end-systolic fiber stress proportionally to the fractional volume added, with stiffer materials improving this attenuation. As a potential therapy, small changes in wall volume ({approx}4.5%) reduce elevated border zone fiber stresses from mean end-systole levels of 28.2 kPa (control) to 23.3 kPa (treatment), similar to levels of 22.5 kPA computed in remote regions. In the infarct, injection improves ejection fraction and the stroke volume/end-diastolic volume relationship but has no effect on the stroke volume/end-diastolic pressure relationship.

Conclusions--Simulations indicate that the addition of noncontractile material to a damaged left ventricular wall has important effects on cardiac mechanics, with potentially beneficial reduction of elevated myofiber stresses, as well as confounding changes to clinical left ventricular metrics.


Key words: heart failure • infarction • mechanics • myocardium • stress




This article has been cited by other articles:


Home page
Eur Heart JHome page
R. de Silva, A. N. Raval, M. Hadi, K. M. Gildea, A. C. Bonifacino, Z.-X. Yu, Y. Y. Yau, S. F. Leitman, S. L. Bacharach, R. E. Donahue, et al.
Intracoronary infusion of autologous mononuclear cells from bone marrow or granulocyte colony-stimulating factor-mobilized apheresis product may not improve remodelling, contractile function, perfusion, or infarct size in a swine model of large myocardial infarction
Eur. Heart J., July 2, 2008; 29(14): 1772 - 1782.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Feygin, Q. Hu, C. Swingen, and J. Zhang
Relationships between regional myocardial wall stress and bioenergetics in hearts with left ventricular hypertrophy
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2313 - H2321.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
N. Bonaros, R. Rauf, E. Werner, B. Schlechta, E. Rohde, A. Kocher, J. Bonatti, and G. Laufer
Neoangiogenesis after combined transplantation of skeletal myoblasts and angiopoietic progenitors leads to increased cell engraftment and lower apoptosis rates in ischemic heart failure
Interactive CardioVascular and Thoracic Surgery, April 1, 2008; 7(2): 249 - 255.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. Landa, L. Miller, M. S. Feinberg, R. Holbova, M. Shachar, I. Freeman, S. Cohen, and J. Leor
Effect of Injectable Alginate Implant on Cardiac Remodeling and Function After Recent and Old Infarcts in Rat
Circulation, March 18, 2008; 117(11): 1388 - 1396.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Menasche, O. Alfieri, S. Janssens, W. McKenna, H. Reichenspurner, L. Trinquart, J.-T. Vilquin, J.-P. Marolleau, B. Seymour, J. Larghero, et al.
The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial: First Randomized Placebo-Controlled Study of Myoblast Transplantation
Circulation, March 4, 2008; 117(9): 1189 - 1200.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. R. Gaudette and I. S. Cohen
Cardiac Regeneration: Materials Can Improve the Passive Properties of Myocardium, but Cell Therapy Must Do More
Circulation, December 12, 2006; 114(24): 2575 - 2577.
[Full Text] [PDF]